0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Off-Center Fold |

Papulopustular Eruptions in a 32-Year-Old Woman After Lung Cancer Treatment—Diagnosis

Arch Dermatol. 2011;147(6):735-740. doi:10.1001/archdermatol.2011.127-b.
Text Size: A A A
Published online

Extract

REFERENCES
Ciardiello  FTortora  G EGFR antagonists in cancer treatment. N Engl J Med 2008;358 (11) 1160- 1174
PubMed Link to Article[[XSLOpenURL/10.1056/NEJMra0707704]]
Agero  ALDusza  SWBenvenuto-Andrade  CBusam  KJMyskowski  PHalpern  AC Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 2006;55 (4) 657- 670
PubMed Link to Article[[XSLOpenURL/10.1016/j.jaad.2005.10.010]]
Jacot  WBessis  DJorda  E  et al.  Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours. Br J Dermatol 2004;151 (1) 238- 241
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2004.151.issue-1]]
Lacouture  MELai  SE The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to EGFR inhibitors) syndrome. Br J Dermatol 2006;155 (4) 852- 854
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2006.155.issue-4]]
Pérez-Soler  RChachoua  AHammond  LA  et al.  Determinants of tumor response and survival with erlotinib in patients with non–small-cell lung cancer. J Clin Oncol 2004;22 (16) 3238- 3247
PubMed Link to Article[[XSLOpenURL/10.1200/JCO.2004.11.057]]
Dainichi  TTanaka  MTsuruta  NFurue  MNoda  K Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor. Dermatology 2003;207 (3) 324- 325
PubMed Link to Article[[XSLOpenURL/10.1159/000073100]]
Pascual  JCBañuls  JBelinchon  IBlanes  MMassuti  B Trichomegaly following treatment with gefitinib (ZD1839). Br J Dermatol 2004;151 (5) 1111- 1112
PubMed Link to Article[[XSLOpenURL/10.1111/bjd.2004.151.issue-5]]
Boone  SLRademaker  ALiu  DPfeiffer  CMauro  DJLacouture  ME Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology 2007;72 (3-4) 152- 159
PubMed Link to Article[[XSLOpenURL/10.1159/000112795]]
Lacouture  MEBasti  SPatel  JBenson  A  III The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors. J Support Oncol 2006;4 (5) 236- 238
PubMed

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

69 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis

brightcove.createExperiences();